Literature DB >> 10926333

A ten year review of colomycin.

J M Littlewood1, C Koch, P A Lambert, N Høiby, J S Elborn, S P Conway, R Dinwiddie, F Duncan-Skingle.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10926333     DOI： 10.1053/rmed.2000.0834

Source DB:  PubMed          Journal:  Respir Med        ISSN： 0954-6111            Impact factor:   3.415


× No keyword cloud information.
  19 in total

1.  Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Timothy C Smeaton; Kingsley Coulthard
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

2.  Simple method for assaying colistin methanesulfonate in plasma and urine using high-performance liquid chromatography.

Authors:  Jian Li; Robert W Milne; Roger L Nation; John D Turnidge; Kingsley Coulthard; Jason Valentine
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

3.  Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

Authors:  Phillip J Bergen; Jian Li; Craig R Rayner; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Colistin: the phoenix arises.

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

5.  Population pharmacokinetic analysis of colistin in burn patients.

Authors:  Jongtae Lee; Seunghoon Han; Sangil Jeon; Taegon Hong; Wonkeun Song; Heungjeong Woo; Dong-Seok Yim
Journal:  Antimicrob Agents Chemother       Date:  2013-02-25       Impact factor: 5.191

Review 6.  Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature.

Authors:  R Giua; C Pedone; L Cortese; R Antonelli Incalzi
Journal:  Infection       Date:  2013-07-25       Impact factor: 3.553

Review 7.  Measuring and improving respiratory outcomes in cystic fibrosis lung disease: opportunities and challenges to therapy.

Authors:  Edith T Zemanick; J Kirk Harris; Steven Conway; Michael W Konstan; Bruce Marshall; Alexandra L Quittner; George Retsch-Bogart; Lisa Saiman; Frank J Accurso
Journal:  J Cyst Fibros       Date:  2009-10-14       Impact factor: 5.482

8.  Evaluation of colistin susceptibility in multidrug-resistant clinical isolates from cystic fibrosis, France.

Authors:  S Biswas; J-C Dubus; M Reynaud-Gaubert; N Stremler; J-M Rolain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-05-30       Impact factor: 3.267

9.  Comparative efficacy of two doses of nebulized colistimethate in the eradication of Pseudomonas aeruginosa in children with cystic fibrosis.

Authors:  Marie-Sophie Brochet; Anne-Cathrine McDuff; Jean-François Bussières; Elaine Caron; Geneviève Fortin; Denis Lebel; Jacques-Edouard Marcotte
Journal:  Can Respir J       Date:  2007 Nov-Dec       Impact factor: 2.409

Review 10.  New antimicrobial strategies in cystic fibrosis.

Authors:  Mireille van Westreenen; Harm A W M Tiddens
Journal:  Paediatr Drugs       Date:  2010-12-01       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.